THRESHOLD PHARMACEUTICALS INC Financials
moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboardSee who Threshold is hiring next, click here to view […]
THLD
Threshold CEO Named as Finalist for European Inventor Award
[Marketwired] – Threshold Pharmaceuticals, Inc. today announced that Harold E. Barry Selick, Ph.D., Chief Executive Officer of Threshold and Cary L. Queen, Ph.D., President of Galaxy Biotech, have been jointly … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboardSee who Threshold is hiring next, click here to view […]
Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor Conferences
[Marketwired] – Threshold Pharmaceuticals, Inc. today announced that Barry Selick, Ph.D., Threshold’s Chief Executive Officer, will present a company overview at three upcoming investor conferences: moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboardSee who Threshold is hiring next, click here to view […]
Threshold Pharmaceuticals Announces Presentation and Webcast at the 20th Annual Future Leaders in the Biotech Industry Conference
[at noodls] – SOUTH SAN FRANCISCO, CA — (Marketwire) — 04/01/13 — Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold’s Chief Executive Officer, will present a company … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboardSee who Threshold is hiring next, click here to view […]
PropThink: TH-302 Development: In the Shadow of the Competition
[ACN Newswire] – By Jake KingAfter declines in the first half of the week, shares of Threshold Pharmaceuticals (NASDAQ:THLD) rebounded on Thursday morning following an update on the company’s ongoing Phase 2 trial of TH-302 … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboard […]
PropThink: Mark the Calendar; Celsion to Release ThermoDox Trial Results in January
[ACN Newswire] – By Jake KingOncology-focused Celsion Corp. (NASDAQ:CLSN) announced Friday morning that the Phase III HEAT trial met its unblinding milestone, and top-line data will be released in January of 2013, sending … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboard […]
Threshold Pharmaceuticals Announces Presentation and Webcast at Lazard Capital Markets 9th Annual Healthcare Conference
[at noodls] – SOUTH SAN FRANCISCO, CA — (Marketwire) — 11/07/12 — Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold’s Chief Executive Officer, will present a company … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboard […]
Threshold Pharmaceuticals Reports Third Quarter 2012 Financial and Operational Results
[at noodls] – Threshold Pharmaceuticals Reports Third Quarter 2012 Financial and Operational Results SOUTH SAN FRANCISCO, CA — (Marketwire) — 11/02/12 — Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today reported … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboard […]
Threshold Pharmaceuticals Announces Presentation and Webcast at 11th Annual BIO Investor Forum
[at noodls] – Threshold Pharmaceuticals Announces Presentation and Webcast at 11th Annual BIO Investor Forum SOUTH SAN FRANCISCO, CA — (Marketwire) — 10/04/12 — Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboard […]
Threshold Pharmaceuticals Announces Presentation and Webcast at BIOX, Noble Financial Capital Markets’ Life Sciences Exposition
[at noodls] – Threshold Pharmaceuticals Announces Presentation and Webcast at BIOX, Noble Financial Capital Markets’ Life Sciences Exposition SOUTH SAN FRANCISCO, CA — (Marketwire) — 09/19/12 — Threshold Pharmaceuticals, … moreView todays social media effects on THLDView the latest stocks trending across Twitter. Click to view dashboard […]
